Skip to main content

Some Drug-Drug Interactions Involving Psychotropic Agents

  • Chapter
Psychopharmacogenetics

Abstract

The idiosyncracies of drug response and drug-drug interaction are often secondary to the idiosyncracies of individual organ systems because they are affected by such factors as age, youth, disease, or genetically transmitted characteristics. With the multiplicity of psychopharmacologic agents now available, and with the tendencies of many psychiatrists toward prescription of poly-pharmacy, the frequency and variety of psychotropic drug interactions are increasing faster than our ability to discover and adequately analyze the causative components. Our knowledge of the genetic factors influencing these activities is particularly deficient, and the necessary body of animal data upon which to base careful human studies has not yet been suitably developed. Reports of unanticipated psychotropic drug-drug interactions in which genetic factors appear to figure significantly are few and tentative. Some cases of genetically influenced responses involving singly administered agents interacting with organ systems have been reported (Kalow, 1971). Well documented instances of one drug altering the activity of another as a result of genetic factors, such as the inhibition of diphenylhydantoin metabolism by iproniazid in slow acetylators (Kutt and McDowell, 1968) are particularly scarce. Rather than attempt a compendium of annecdotal reports of such cases here, we will devote this brief chapter to an outline of some of the broader mechanisms which we can state with some assurance are fairly consistent components in the interactivity of multiple drugs within living organisms. As further information concerning the role of genetics in these processes is developed in the future, it will probably have to be done with reference to the patterns with which we have thus far seen drug-drug interactions occur when they are influenced by advanced age, disease or trauma to effected organs and tissues, or matters of biochemical compatibility. The following information is presented, therefore, as a construct of both established and theoretically possible occurrences.

This work was supported in part by a grant from the Veterans Administration.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

eBook
USD 16.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 54.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  • KALOW, W. 1971. Genetic factors in adverse drug reactions. J. Clin. Pharmacol. 5: 38.

    Google Scholar 

  • KUTT, H., and McDOWELL, F. 1968. Inhibition of diaphenylhydantoin metabolism in rats and in rat liver microsomes by antitubercular drugs. Neurology 18: 706.

    PubMed  Google Scholar 

  • KOCH-WESER, J., and SELLERS, E. M. 1971. Drug interactions with cumarin anticoagulants. New Eng. J. Med. 285: 487.

    Article  Google Scholar 

  • FANN, W. E., JANOWSKY, D. S., and DAVIS, J. M. 1971. Antagonism of antihypertensive effect of guanethidine by chlorpromazine. Lancet 2: 436.

    Article  PubMed  Google Scholar 

  • DAVIS, J. M., FANN, W. E., GRIFFITH, J. E., and OATES, J. A. 1971. Pharmacological aspects of the treatment of amphetamine abuse: The effects of urinary pH. Adv. Neuropsychpharmacol. 279.

    Google Scholar 

  • DAVIS, J. M., and FANN, W. E. 1970. Lithium. Ann. Rev. Pharmacol. 2: 285.

    Google Scholar 

  • FANN, W. E. 1973. Some clinically important interactions of psychotropic drugs. S. Med. J. 66: 661.

    Article  Google Scholar 

  • FANN, W. E., DAVIS, J. M., JANOWSKY, D. S., SEKERKE, J. J., and SCHMIDT, D. M. 1973. Chlorpromazine: The effects of antacids on its gastrointestinal absorption. J. Clin. Pharm. 388.

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 1975 Plenum Press, New York

About this chapter

Cite this chapter

Fann, W.E., Richman, B.W. (1975). Some Drug-Drug Interactions Involving Psychotropic Agents. In: Eleftheriou, B.E. (eds) Psychopharmacogenetics. Springer, Boston, MA. https://doi.org/10.1007/978-1-4615-7697-6_13

Download citation

  • DOI: https://doi.org/10.1007/978-1-4615-7697-6_13

  • Publisher Name: Springer, Boston, MA

  • Print ISBN: 978-1-4615-7699-0

  • Online ISBN: 978-1-4615-7697-6

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics